Tauriga Sciences, Inc. Presently Configured to Accept the

Tauriga Sciences, Inc. Now Configured to Accept the

The Acceptance of Bitcoin, and These Other Select Cryptocurrencies, Will Improve the Company’s Ability to Transact with Its Global Customer Base

NEW YORK, NY, Feb. 12, 2021 (GLOBE NEWSWIRE) – – through NewMediaWire – – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga†or the “Companyâ€), an income creating, enhanced life sciences organization, with a restrictive line of CBD and CBG mixed Supplement biting gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as a continuous Pharmaceutical Development drive, today reported that it is currently arranged to acknowledge the accompanying digital forms of money as installment choices on its E-Commerce Platform (www.taurigum.com): Bitcoin (“BTCâ€), Etherium (“ETHâ€), Bitcoin Cash (“BCHâ€), Dai (“DAIâ€), and Litecoin (“LTCâ€).  As the Company keeps on developing its client base, it is critical to be basically as accommodative as conceivable to the necessities of its clients — across the globe.    


Tauriga Sciences, Inc. (TAUG) is an income creating, expanded life sciences organization, occupied with a few significant business exercises and initiatives. The organization fabricates and conveys a few restrictive retail items and product offerings, basically centered around the Cannabidiol (“CBDâ€) and Cannabigerol (“CBGâ€) Edibles market segment.  The fundamental product offering, marked as Tauri-Gumâ„¢, comprises of an exclusive enhancement biting gum that is Kosher guaranteed, Halal affirmed, and Vegan Formulated (CBD Infused Tauri-Gumâ„¢ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gumâ„¢ Flavors: Peach-Lemon, Black Currant) and (Vitamin C + Zinc “Immune Booster†Flavor: Pear Bellini).  The Company’s commercialization methodology comprises of a wide cluster of retail clients, wholesalers, and a quickly developing E-Commerce business fragment (E-Commerce site: www.taurigum.com). If it’s not too much trouble, visit our corporate site, for extra data, as well as requests, at http://www.tauriga.com

Complementary to the Company’s retail business, is its continuous Pharmaceutical Development initiative.â  This connects with the improvement of a proposed Pharmaceutical grade variant of Tauri-Gumâ„¢, for sickness guideline (explicitly intended for the accompanying sign: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company declared that it had recorded a temporary U.S. patent application covering its drug grade adaptation of Tauri-Gumâ„¢.â  The Patent, recorded with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENTâ€.  On December 18, 2020, the Company revealed that it had gone into a Master Services Agreement with CSTI to lead the Company

Source link

Leave a Reply

Your email address will not be published.

I agree to the Terms & Conditions and Privacy Policy.

Related Posts